Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene

被引:36
作者
Hao, Le T. [1 ,2 ]
Burghes, Arthur H. M. [3 ]
Beattie, Christine E. [1 ,2 ]
机构
[1] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
来源
MOLECULAR NEURODEGENERATION | 2011年 / 6卷
关键词
SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MOUSE MODEL; NEUROMUSCULAR-JUNCTIONS; TRANSGENIC ZEBRAFISH; SINGLE NUCLEOTIDE; AXON OUTGROWTH; PROTEIN; MICE; IDENTIFICATION;
D O I
10.1186/1750-1326-6-24
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Animal models of human diseases are essential as they allow analysis of the disease process at the cellular level and can advance therapeutics by serving as a tool for drug screening and target validation. Here we report the development of a complete genetic model of spinal muscular atrophy (SMA) in the vertebrate zebrafish to complement existing zebrafish, mouse, and invertebrate models and show its utility for testing compounds that alter SMN2 splicing. Results: The human motoneuron disease SMA is caused by low levels, as opposed to a complete absence, of the survival motor neuron protein (SMN). To generate a true model of SMA in zebrafish, we have generated a transgenic zebrafish expressing the human SMN2 gene (hSMN2), which produces only a low amount of full-length SMN, and crossed this onto the smn(-/-) background. We show that human SMN2 is spliced in zebrafish as it is in humans and makes low levels of SMN protein. Moreover, we show that an antisense oligonucleotide that enhances correct hSMN2 splicing increases full-length hSMN RNA in this model. When we placed this transgene on the smn mutant background it rescued the neuromuscular presynaptic SV2 defect that occurs in smn mutants and increased their survival. Conclusions: We have generated a transgenic fish carrying the human hSMN2 gene. This gene is spliced in fish as it is in humans and mice suggesting a conserved splicing mechanism in these vertebrates. Moreover, antisense targeting of an intronic splicing silencer site increased the amount of full length SMN generated from this transgene. Having this transgene on the smn mutant fish rescued the presynaptic defect and increased survival. This model of zebrafish SMA has all of the components of human SMA and can thus be used to understand motoneuron dysfunction in SMA, can be used as an vivo test for drugs or antisense approaches that increase full-length SMN, and can be developed for drug screening.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
    Calucho, Maite
    Bernal, Sara
    Alias, Laura
    March, Francesca
    Vencesla, Adoracion
    Rodriguez-Alvarez, Francisco J.
    Aller, Elena
    Fernandez, Raquel M.
    Borrego, Salud
    Milian, Jose M.
    Hernandez-Chico, Concepcion
    Cusco, Ivon
    Fuentes-Prior, Pablo
    Tizzano, Eduardo F.
    NEUROMUSCULAR DISORDERS, 2018, 28 (03) : 208 - 215
  • [42] Repeated AAV9 Titer Determination in a Presymptomatic SMA Patient with Three SMN2 Gene Copies - A Case Report
    Eisenkoelbl, Astrid
    Puehringer, Manuel
    JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (02) : 493 - 498
  • [43] 270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10-12 March, 2023, Hoofddorp, the Netherlands
    Abiusi, Emanuela
    Costa-Roger, Mar
    Bertini, Enrico Silvio
    Tiziano, Francesco Danilo
    Tizzano, Eduardo F.
    NEUROMUSCULAR DISORDERS, 2024, 34 : 114 - 122
  • [44] Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
    Ratni, Hasane
    Ebeling, Martin
    Baird, John
    Bendels, Stefanie
    Bylund, Johan
    Chen, Karen S.
    Denk, Nora
    Feng, Zhihua
    Green, Luke
    Guerard, Melanie
    Jablonski, Philippe
    Jacobsen, Bjoern
    Khwaja, Omar
    Kletzl, Heidemarie
    Ko, Chien-Ping
    Kustermann, Stefan
    Marquet, Anne
    Metzger, Friedrich
    Mueller, Barbara
    Naryshkin, Nikolai A.
    Paushkin, Sergey V.
    Pinard, Emmanuel
    Poirier, Agnes
    Reutlinger, Michael
    Weetall, Marla
    Zeller, Andreas
    Zhao, Xin
    Mueller, Lutz
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (15) : 6501 - 6517
  • [45] Evaluation of the SMN and NAIP Genes in a Family: Homozygous Deletion of the SMN2 Gene in the Fetus and Outcome of the Pregnancy
    Cogulu, Ozgur
    Durmaz, Burak
    Pehlivan, Sacide
    Alpman, Asude
    Ozkinay, Ferda
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (03) : 287 - 288
  • [46] Antisense oligonucleotides targeting the SMN2 promoter region enhance SMN2 expression in spinal muscular atrophy cell lines and mouse model
    Wang, Jia
    Bai, Jinli
    OuYang, Shijia
    Wang, Hong
    Jin, Yuwei
    Peng, Xiaoyin
    Ge, Xiushan
    Jiao, Hui
    Zou, Jizhen
    He, Cai
    Xiao, Ping
    Song, Fang
    Qu, Yujin
    HUMAN MOLECULAR GENETICS, 2022, 31 (10) : 1635 - 1650
  • [47] Novel Modification of a Confirmatory SMA Sequencing Assay that Can Be Used to Determine SMN2 Copy Number
    Kumar, Binod
    Barton, Samantha
    Kordowska, Jolanta
    Eaton, Roger B.
    Counihan, Anne M.
    Hale, Jaime E.
    Comeau, Anne Marie
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2021, 7 (03)
  • [48] Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies
    McMillan, Hugh J.
    Gonorazky, Hernan
    Campbell, Craig
    Chrestian, Nicolas
    Crone, Megan
    Dowling, James J.
    Joyal, Kristina
    Kolski, Hanna
    Leung, Ed
    Mackenzie, Alex
    Mah, Jean K.
    McAdam, Laura
    Nigro, Elisa
    Nguyen, Cam-Tu
    Oskoui, Maryam
    Poulin, Chantal
    Sheriko, Jordan
    Tarnopolsky, Mark
    Vajsar, Jiri
    Yaworski, Amanda
    Selby, Kathryn
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024,
  • [49] Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III
    Zheleznyakova, Galina Yu
    Kiselev, Anton V.
    Vakharlovsky, Viktor G.
    Rask-Andersen, Mathias
    Chavan, Rohit
    Egorova, Anna A.
    Schioth, Helgi B.
    Baranov, Vladislav S.
    BMC MEDICAL GENETICS, 2011, 12
  • [50] A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2
    Jodelka, Francine M.
    Ebert, Allison D.
    Duelli, Dominik M.
    Hastings, Michelle L.
    HUMAN MOLECULAR GENETICS, 2010, 19 (24) : 4906 - 4917